Spots Global Cancer Trial Database for endoscopic biopsy
Every month we try and update this database with for endoscopic biopsy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery | NCT00659113 | Esophageal Canc... | cisplatin tegafur-gimerac... cytology specim... endoscopic biop... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Screening Methods in Finding Lung Cancer Early in Current or Former Smokers | NCT00751660 | Lung Cancer Tobacco Use Dis... | laboratory biom... screening quest... bronchoscopic a... computed tomogr... endoscopic biop... quality-of-life... | 50 Years - 75 Years | British Columbia Cancer Agency | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer | NCT00019201 | Head and Neck C... Lung Cancer | cytology specim... immunohistochem... sputum cytology bronchoscopic a... bronchoscopy comparison of s... endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer | NCT02877056 | Colorectal Canc... | Endoscopy | 18 Years - | M.D. Anderson Cancer Center | |
| Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus | NCT00987857 | Esophageal Canc... Precancerous Co... | 2 yearly endosc... comparison of s... diagnostic endo... endoscopic biop... endoscopic proc... quality-of-life... screening metho... | 18 Years - 120 Years | Gloucestershire Hospitals NHS Foundation Trust | |
| Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | NCT00960427 | Colorectal Canc... | systemic chemot... RNA analysis gene expression... reverse transcr... immunohistochem... laboratory biom... endoscopic biop... neoadjuvant the... sigmoidoscopy radiation thera... | 18 Years - 80 Years | Barbara Ann Karmanos Cancer Institute | |
| Distribution of Helicobacter Pylori After Gastrectomy | NCT03419936 | Helicobacter Py... | Endoscopic biop... | 19 Years - 75 Years | Asan Medical Center | |
| Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer | NCT03641313 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Gast... Metastatic Gast... Unresectable Ga... Unresectable Ga... | Berzosertib Computed Tomogr... Endoscopic Biop... Irinotecan Magnetic Resona... | 18 Years - | National Cancer Institute (NCI) | |
| Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | NCT00602602 | Pancreatic Canc... | bevacizumab fluorouracil gemcitabine hyd... oxaliplatin immunohistochem... laboratory biom... conventional su... endoscopic biop... laparoscopy radiation thera... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer | NCT04929392 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Esophageal Aden... Esophageal Squa... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... | Carboplatin Endoscopic Biop... External Beam R... Lenvatinib Mesy... Paclitaxel Pembrolizumab Resection | 18 Years - | City of Hope Medical Center | |
| Distribution of Helicobacter Pylori After Gastrectomy | NCT03419936 | Helicobacter Py... | Endoscopic biop... | 19 Years - 75 Years | Asan Medical Center | |
| Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer | NCT04929392 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Esophageal Aden... Esophageal Squa... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... | Carboplatin Endoscopic Biop... External Beam R... Lenvatinib Mesy... Paclitaxel Pembrolizumab Resection | 18 Years - | City of Hope Medical Center | |
| Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients | NCT05078866 | Lynch Syndrome | Adenoviral Tumo... Biospecimen Col... Endoscopic Biop... MVA Tumor-speci... Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer | NCT00081003 | Breast Cancer | gene expression... protein express... cytology specim... laboratory biom... physiologic tes... breast duct lav... endoscopic biop... study of high r... | 18 Years - 64 Years | National Cancer Institute (NCI) | |
| S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery | NCT00659113 | Esophageal Canc... | cisplatin tegafur-gimerac... cytology specim... endoscopic biop... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer | NCT00019201 | Head and Neck C... Lung Cancer | cytology specim... immunohistochem... sputum cytology bronchoscopic a... bronchoscopy comparison of s... endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer | NCT00019201 | Head and Neck C... Lung Cancer | cytology specim... immunohistochem... sputum cytology bronchoscopic a... bronchoscopy comparison of s... endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers | NCT02642809 | Esophageal Neop... Esophageal Canc... Cancer of the E... | Pembrolizumab Brachytherapy Endoscopic biop... Computed tomogr... Peripheral bloo... | 18 Years - | Washington University School of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
